1. COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial. (21st November 2020) Authors: Camilleri, Marquita; Sive, Jonathan; Wilson, William; Pang, Gavin; Jenner, Richard; Phillips, Elizabeth; Popat, Rakesh; Ramasamy, Karthik; Bygrave, Ceri; Dadaga, Tushhar; Streetly, Matthew; Cavenagh, James; Chapman, Mike; Barrington, Sally; Pike, Lucy; Owen, Roger; Clifton‐Hadley, Laura; Yong, Kwee Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma. (10th June 2020) Authors: Bygrave, Ceri; Pawlyn, Charlotte; Davies, Faith; Craig, Zoe; Cairns, David; Hockaday, Anna; Jenner, Matthew; Cook, Gordon; Drayson, Mark; Owen, Roger; Gregory, Walter; Morgan, Gareth; Jackson, Graham; Kaiser, Martin Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset. Issue 6 (26th June 2022) Authors: Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al-Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander... Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients. (31st January 2023) Authors: Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al‐Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander... Journal: British journal of haematology Issue: Volume 201:Number 1(2023) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study. Issue 1 (31st December 2022) Authors: Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Firas, Al-Kaisi; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander... Journal: Hematology Issue: Volume 27:Issue 1(2022) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience. Issue 6 (12th May 2021) Authors: Maouche, Nadjoua; Kishore, Bhuvan; Jenner, Matthew W.; Boyd, Kevin; Bhatti, Zara; Bird, Sarah Anne; Chander, Gurvin; Robinson, Rebecca; Vallance, Grant D.; Offer, Mark; Kothari, Jaimal; Peniket, Andy; Aitchison, Robin; Dungarwalla, Moez; Collings, Freya; Bygrave, Ceri; Ramasamy, Karthik Journal: Leukemia & lymphoma Issue: Volume 62:Issue 6(2021) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy. (10th June 2020) Authors: Cook, Gordon; John Ashcroft, A; Pratt, Guy; Popat, Rakesh; Ramasamy, Karthik; Kaiser, Martin; Jenner, Matthew; Henshaw, Sarah; Hall, Rachel; Sive, Jonathan; Stern, Simon; Streetly, Matthew; Bygrave, Ceri; Soutar, Richard; Rabin, Neil; Jackson, Graham H Journal: British journal of haematology Issue: Volume 190:Number 2(2020) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. Issue 11 (17th November 2022) Authors: Royle, Kara-Louise; Coulson, Amy Beth; Ramasamy, Karthik; Cairns, David A; Hockaday, Anna; Quezada, Sergio; Drayson, Mark; Kaiser, Martin; Owen, Roger; Auner, Holger W; Cook, Gordon; Meads, David; Olivier, Catherine; Barnard, Lorna; Lambkin, Rhiannon; Paterson, Andrea; Dawkins, Bryony; Chapman, M... Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. (1st March 2021) Authors: Camilleri, Marquita; Cuadrado, Maria; Phillips, Elizabeth; Wilson, William; Jenner, Richard; Pang, Gavin; Kamora, Sumaiya; Streetly, Matthew; Popat, Rakesh; Bygrave, Ceri; Owen, Roger; Cavenagh, James; Chapman, Mike; Sive, Jonathan; Eccersley, Lydia; Sheaff, Michael; Benjamin, Reuben; Ramasamy, K... Journal: British journal of haematology Issue: Volume 193:Number 4(2021) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗